What is Quire?
Quire operates at the intersection of clinical informatics and predictive analytics, offering a sophisticated software platform designed to enhance the efficacy of value-based care models. The company's proprietary technology utilizes artificial intelligence to parse unstructured text from electronic medical records and clinical notes, transforming fragmented data into coherent, predictive insights. By identifying high-risk patient cohorts and elucidating the underlying drivers of health outcomes, Quire enables healthcare organizations to allocate intervention resources with unprecedented precision. This capability is essential for providers navigating the complexities of modern healthcare, where the mandate to improve patient health while simultaneously controlling costs has become the industry standard. Headquartered in Memphis, Tennessee, the company has established a robust market presence by addressing the critical need for data-driven decision support in clinical environments.
How much funding has Quire raised?
Quire has raised a total of $79K across 1 funding round:
Debt
$79K
Debt (2021): $79K with participation from PPP
Key Investors in Quire
TriStar Technology Ventures
A venture capital firm specializing in early-stage and growth-stage investments within the healthcare and life sciences sectors.
Innova
A Memphis-based venture capital firm focused on supporting high-growth technology and healthcare companies in the Mid-South region.
Pittco
A private investment firm with a diverse portfolio that includes strategic backing for innovative healthcare and technology enterprises.
What's next for Quire?
With the successful acquisition of this latest capital, Quire is well-positioned to accelerate its product development roadmap and expand its footprint within the value-based care market. The strategic focus will likely center on enhancing the predictive accuracy of its AI algorithms and deepening integration capabilities with existing electronic medical record systems. As healthcare providers face increasing pressure to demonstrate measurable improvements in patient outcomes, Quire's ability to convert clinical narrative into strategic resource allocation will be a key differentiator. The company is expected to leverage this investment to scale its sales and marketing efforts, targeting larger health systems that require sophisticated tools to manage the financial and clinical risks associated with population health management. By maintaining its focus on high-impact clinical interventions, Quire is poised to remain a significant contributor to the evolution of digital health infrastructure.
See full Quire company page
